Drug-free macromolecular therapeutics: Induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface

Angewandte Chemie - International Edition

Volumn 49, Issue 8, 2010, Pages 1451-1455

  Wu, Kuangshi ^a   Liu, Jihua ^a   Johnson, Russell N ^a   Yang, Jiyuan ^a   Kopeček, Jindřich ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Antibodies; Apoptosis; Biorecognition; Coiled coils; Peptide polymer conjugates

Indexed keywords

APOPTOSIS; BIORECOGNITION; COILED COIL; COILED COILS; POLYMER CONJUGATE;

ANTIGENS; CELL DEATH; CELL MEMBRANES; FUNCTIONAL POLYMERS; PEPTIDES;

ANTIBODIES;

ANTIGEN; CROSS LINKING REAGENT; PEPTIDE; POLYMER;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIGENS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CIRCULAR DICHROISM; CROSS-LINKING REAGENTS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES; POLYMERS;

EID: 76649140507     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.200906232     Document Type: Article

References (30)

1. a) J. Kopeček, Eur. J. Pharm. Sci. 2003, 20, 1;
2. b)J. Kopeček, Biomaterials 2007, 28, 5185;
3. c) J. Kopeček, J. Yang, Polym. Int. 2007, 56,1078;
4. d) J. Kopeček, Nature 2002, 417, 88.
5. C. Wang, R. J. Stewart, J. Kopeček, Nature 1999, 397, 417.
6. a) J. Yang, C. Xu, C. Wang, J. Kopeček, Biomacromolecules 2006, 7, 1187;
7. b)J. Yang, K. Wu, Č. Koňák, J. Kopeček, Biomacromolecules 2008, 9, 510.
8. a) C. Kosmas, K. Stamatopoulos, N. Stavroyianni, N. Tsavaris, T. Papadaki, Leukemia 2002,16, 2004;
9. b) J. P. Deans, H. Li, M. J. Polyak, Immunology 2002,107,176;
10. c) J. T. Golay, E. A. Clark, P. C. Beverley, J. Immunol. 1985, 135, 3795 ;
11. d) J. K. Bubien, L. J. Zhou, P. D. Bell, R. A. Frizzell, T. F. Tedder, J. Cell Biol. 1993, 121, 1121;
12. e) O.W. Press, A. G. Farr, K. I. Borroz, S. K. Anderson, P. J. Martin, Cancer Res. 1989, 49, 4906;
13. f) O. W. Press, F. Appelbaum, J. A. Ledbetter, P. J. Martin, J. Zarling, P. Kidd, E. D. Thomas, Blood 1987, 69, 584.
14. E. A. Clark, G. Shu, J. A. Ledbetter, Proc. Natl. Acad. Sci. USA 1985, 82, 1766.
15. a) K. D. Fowers, J. Callahan, P. Byron, J. Kopeček, J. Drug Targeting 2001, 9, 281;
16. b) R. N. Johnson, P. Kopečková, J. Kopeček, Bioconjugate Chem. 2009, 20, 129.
17. a) N. Zhang, L. A. Khawli, P. Hu, A. L. Epstein, Clin. Cancer Res. 2005, 11, 5971;
18. b) M. A. Ghetie, H. Bright, E. S. Vitetta, Blood 2001, 97, 1392.
19. a) J. K. Hofmeister, D. Cooney, K. M. Coggeshall, Blood Cells Mol. Dis. 2000, 26,133;
20. b) D. Shan, J. A. Ledbetter, O. W. Press, Blood 1998, 91, 1644.
21. a) J. Kopeček, P. Kopečková, T. Minko, Z.-R. Lu, Eur. J. Pharm. Biopharm. 2000, 50, 61;
22. b) J. Kopeček, P. Kopečková, Adv. Drug Delivery Rev. 2010, DOI: 10.10.16/j.addr.2009.10.004.
23. a) C. M. Peterson, J. M. Lu, Y. Sun, C. A. Peterson, J.-G. Shiah, R. C. Straight, J. Kopeček, Cancer Res. 1996, 56, 3980;
24. b) J.-G. Shiah, M. Dvořák, P. Kopečková, Y. Sun, C. M. Peterson, J. Kopeček, Eur. J. Cancer 2001, 37, 131;
25. c) T. Minko, P. Kopečková, J. Kopeček, Int. J. Cancer 2000, 86, 108;
26. d) P. A. Vasey, C. Twelves, S. B. Kaye, P. Wilson, R. Morrison, R. Duncan, A. Thomson, L. Murray, T. E. Hilditch, T. Murray, S. Burtles, E. Frigerio, D. Fraier, J. Cassidy, Clin. Cancer Res. 1999, 5,83.
27. K. C. Anderson, M. P. Bates, B. L. Slaugenhoupt, G. S. Pinkus, S. F. Schlossman, L. M. Nadler, Blood 1984, 63,1424.
28. a) A. David, P. Kopečková, A. Rubinstein, J. Kopeček, Bioconjugate Chem. 2001, 12, 890;
29. b) H. Ding, W M. Prodinger, J. Kopeček, Bioconjugate Chem. 2006,17, 514;
30. c) H. Ding, W. M. Prodinger, J. Kopeček, Biomacromolecules 2006, 7, 3037.